"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

Research presented at this year's Psych Congress meeting in Boston included a randomized trial of esketamine (Spravato) ...

Following esketamine for TRD, PHQ-9 scores significantly reduced by 5.9 in the overall cohort and 6.0 in the TMS-naïve subgroup. Sustained use of esketamine nasal spray significantly improves ...

it is important that ketamine treatment be administered in a medically supervised setting. Esketamine is currently FDA-indicated as an adjunctive treatment after two failed antidepressant trials.

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Forty-five patients were treated twice weekly for up to four weeks with intravenous ketamine or esketamine. Overall, 39 percent achieved a clinical response to treatment and 13 percent achieved ...

Objective To investigate the efficacy of esketamine as an adjuvant to epidural ropivacaine for labour analgesia by determining its effect on the median effective concentration (EC 50) in a 20 ml ...